A minority of the relatives of BRCA1/2 mutation carriers (n = 38) was enrolled within the Col-BC/OC-Family study; the majority (n = 213) were recruited through unselected probands from the Col-BCCC study. This evidence concerns the gene BRCA1 and breast cancer.